Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites

Clinical Cancer Research

Volumn 17, Issue 23, 2011, Pages 7248-7264

  Zhao, Mei ^a   Sano, Daisuke ^a   Pickering, Curtis R ^a   Jasser, Samar A ^a   Henderson, Ying C ^a   Clayman, Gary L ^a   Sturgis, Erich M ^a   Ow, Thomas J ^a   Lotan, Reuben ^a   Carey, Thomas E ^b   Sacks, Peter G ^c   Grandis, Jennifer R ^d   Sidransky, David ^e   Heldin, Nils Erik ^f   Myers, Jeffrey N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GENETICS; CANCER STAGING; CELL STRUCTURE; CULTURE MEDIUM; CUTANEOUS SQUAMOUS CELL CARCINOMA; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMORTALIZED PRIMARY KERATINOCYTE; IN VITRO STUDY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHORT TANDEM REPEAT; THYROID CANCER; TUMOR LOCALIZATION;

ALPHAPAPILLOMAVIRUS; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DNA, VIRAL; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; LEUKOPLAKIA, ORAL; MICROSATELLITE REPEATS; THYROID NEOPLASMS;

EID: 80455136301     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0690     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002.CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Batsakis J. Tumors of the head and neck. Baltimore: Williams and Wilkins; 1979.
4. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-16. (Pubitemid 40344442)
5. Ansari MH. Salivary gland tumors in an Iranian population: a retrospective study of 130 cases. J Oral Maxillofac Surg 2007;65:2187-94. (Pubitemid 47588590)
6. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757-66.
7. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA. False leukemialymphoma cell lines: an update on over 500 cell lines. Leukemia 2003;17:416-26. (Pubitemid 36266920)
8. Dirks WG, Drexler HG. Authentication of cancer cell lines by DNA fingerprinting. Methods Mol Med 2004;88:43-55.
9. Ruiz Bravo N, Gottesman M. Notice regarding authentication of cultured cell lines #NOT-OD-08-017. Bethesda (MD): NIH; 2007.
10. AACR Journals: Instructions for Authors [2011]. Available from: http://cancerres.aacrjournals.org/site/misc/ifora.xhtml.
11. Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 2007;29:163-88. (Pubitemid 46167784)
12. Lansford C, Grenman R, Bier H, Somers KD, Kim SY, Whiteside TL, et al. Head and neck cancers. In: Masters JR, Palsson B, editors. Human cell culture. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1999. p. 185-255.
13. Brenner JC, Graham MP, Kumar B, Saunders LM, Kupfer R, Lyons RH, et al. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 2010;32:417-26.
14. Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci US A 2001;98:8012-7. (Pubitemid 32642678)
15. American Type Culture Collection STR Profile Database [1998]. Available from: http://www.atcc.org/CulturesandProducts/CellBiology/STRProfileDatabase/ tabid/174/Default.aspx.
16. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 2008;93:4331-41. (Pubitemid 352789529)
17. Park NH, Min BM, Li SL, Huang MZ, Cherick HM, Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991;12:1627-31.
18. Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM, Park NH. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Eur J Cancer B Oral Oncol 1994;30B:338-45. (Pubitemid 24309216)
19. Gupta AK, Lee JH, Wilke WW, Quon H, Smith G, Maity A, et al. Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT. Int J Radiat Oncol Biol Phys 2009;74:928-33.
20. Chen Z, Storthz KA, Shillitoe EJ. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res 1997;57:1614-9. (Pubitemid 27175583)
21. Langendijk JA, Psyrri A. The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol 2010;21:1931-4.
22. Lacroix M. Persistent use of "false" cell lines. Int J Cancer 2008;122:1-4. (Pubitemid 350209971)
23. Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther 2009;8:713-24.
24. Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer 2010;127:1-8.
25. Dirks WG, MacLeod RA, Nakamura Y, Kohara A, Reid Y, Milch H, et al. Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines. Int J Cancer 2010;126:303-4.
26. Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev 2002;2:315-9. (Pubitemid 37336517)
27. Giard DJ, Aaronson SA,TodaroGJ, Arnstein P,KerseyJH,Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.
28. Atlas of Genetics and Cytogenetics in Oncology and Haematology [1999]. Available from: http://atlasgeneticsoncology.org/Anomalies/YlossID1089.html.
29. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-35. (Pubitemid 47463055)
30. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781-9.
31. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
32. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, KochWM,et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
33. Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007;357:2552-61. (Pubitemid 350294222)
34. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007;28:622-9. (Pubitemid 46744292)
35. Sano D, Xie T, Ow TJ, Zhao M, Pickering CR, Zhou G, et al. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res 2011;17:6658-70.
36. Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM, et al. Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene 2007;26:1459-67.
37. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev 2009;9:265-73.